Concepedia

Germaine D. Agollah

GD

11

Publications

809

Citations

11

H-Index

2009

Active since

Affiliations

The University of Texas MD Anderson Cancer Center(Current)

The University of Texas Health Science Center at Houston

Brown Foundation

University of California San Diego

Arizona Liver Health

Germaine D. Agollah is an author at The University of Texas MD Anderson Cancer Center specializing in medicine, lymphatic system, and engineering.

Top concepts

Publications per year

2009–2023

11

Publications

11

Randomized, Controlled Trial of the FGF21 Analogue Pegozafermin in NASH

Rohit Loomba, Arun J. Sanyal, Kris V. Kowdley et al. · New England Journal of Medicine · 2023 · 382 citations · Full text

Immunoconjugated gold nanoshell-mediated photothermal ablation of trastuzumab-resistant breast cancer cells

Laura B. Carpin, Lissett R. Bickford, Germaine D. Agollah et al. · Breast Cancer Research and Treatment · 2010 · 111 citations

, , +7

The FGF21 analog pegozafermin in severe hypertriglyceridemia: a randomized phase 2 trial

Deepak L. Bhatt, Harold Bays, Michael Miller et al. · Nature Medicine · 2023 · 86 citations · Full text

Silica-gold nanoshells as potential intraoperative molecular probes for HER2-overexpression in ex vivo breast tissue using near-infrared reflectance confocal microscopy

Lissett R. Bickford, Germaine D. Agollah, Rebekah A. Drezek et al. · Breast Cancer Research and Treatment · 2009 · 52 citations

, , +8

Two-Dimensionality of Yeast Colony Expansion Accompanied by Pattern Formation

Lin Chen, Javad Noorbakhsh, Rhys Adams et al. · PLoS Computational Biology · 2014 · 51 citations · Full text

, , +8

Rows per page

1–5 of 11